Dennis Phillip Andrew sold NBP

June 17, 2026 · Form 4 insider transaction

Dennis Phillip Andrew sold 10,302 shares of NovaBridge Biosciences at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Disposed (sell-side)
Shares
10,302
Price
$0.00
Total value
N/A
RoleOfficer
SecurityRestricted Share Units
Transaction codeM: Option exercise
Transaction dateJune 17, 2026
Filing dateJune 22, 2026
Shares owned after82,422
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.; Reported securities represent ADSs.; On June 17, 2024, the Reporting Person was granted 164,840 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 17th day of each third month.; The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.

View the original Form 4 on SEC EDGAR